Want to join the conversation?
$ABT said the FDA has approved its Absorb bioresorbable heart stent, making the first-of-its-kind medical device commercially available to treat people with coronary artery disease in the US. The company plans to offer Absorb to hospitals in the US, starting with interventional cardiology centers that participated in Absorb clinical trials.
Wow! $MCD scores again.